Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2025

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Presenter: Donald Cutlip

October 27, 2025

Presentation TCT 2025

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Presenter: Donald Cutlip

October 26, 2025

Presentation TCT 2024

REC/CAGE FREE

Presenter: Donald Cutlip

October 30, 2024

Presentation TCT 2023

SELUTION DCB

Presenter: Donald Cutlip

October 25, 2023

Presentation TCT 2023

Status Quo on SELUTION4ISR & SELUTION4DeNovo

Presenter: Donald Cutlip

October 24, 2023

Presentation TCT 2022

When Do I Use Mechanical Support for Left Main PCI?

Presenter: Donald Cutlip

September 18, 2022

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation

9-Month Clinical and Angiographic Outcomes With Cobra Polyzene-F Stent

Presenter: Donald Cutlip

February 03, 2017

Presentation TCT 2016

LEADERS FREE: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip

October 31, 2016

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Regulation of Cardiovascular Devices in Europe: A Need for Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Angeles Alonso Garcia

September 15, 2014

Presentation TCT 2014

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Jack C. Lewin

September 15, 2014

Presentation TCT 2014

Keynote Lecture III: Updates and Accomplishments of the New CDRH Early Feasibility Program

Presenter: Andrew Farb, Juan F. Granada, Donald Cutlip

September 15, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Advertisement

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

REC/CAGE FREE

SELUTION DCB

Status Quo on SELUTION4ISR & SELUTION4DeNovo

When Do I Use Mechanical Support for Left Main PCI?

The Methods for Coronary Stent Development

Emerging Thromboresistant BMS 1: Cobra PzF Stents

9-Month Clinical and Angiographic Outcomes With Cobra Polyzene-F Stent

LEADERS FREE: Pros and Cons

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Regulation of Cardiovascular Devices in Europe: A Need for Change

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Keynote Lecture III: Updates and Accomplishments of the New CDRH Early Feasibility Program

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content